We are live on ! Find out more
RVMD icon

Revolution Medicines
RVMD

117 hedge funds and large institutions have $1.85B invested in Revolution Medicines in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more call options, than puts

Call options by funds: $2.28M | Put options by funds: $1.27M

38% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 29

27% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 15

13% more funds holding in top 10

Funds holding in top 10: 8 → 9 (+1)

3% more funds holding

Funds holding: 114 → 117 (+3)

1.25% more ownership

Funds ownership: 98.26% → 99.51% (+1.3%)

7% less capital invested

Capital invested by funds: $1.99B → $1.85B (-$144M)

Holders
117
Holders Change
+3
Holders Change %
+2.63%
% of All Funds
1.8%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.14%
New
19
Increased
40
Reduced
29
Closed
15
Calls
$2.28M
Puts
$1.27M
Net Calls
+$1.01M
Net Calls Change
+$1.03M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$58.1M
2
BlackRock
BlackRock
New York
+$10.4M
3
Citadel Advisors
Citadel Advisors
Florida
+$7.62M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.31M
5
Citigroup
Citigroup
New York
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$47.8M
2
CAM
Cormorant Asset Management
Massachusetts
-$20.1M
3
BI
BVF Inc
California
-$19M
4
DM
Deerfield Management
New York
-$19M
5
CC
Casdin Capital
New York
-$12.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
HMC
26
Harvard Management Company
Massachusetts
$16.9M – – –
Northern Trust
27
Northern Trust
Illinois
$14.1M +$39.1K +1,387 +0.2%
Norges Bank
28
Norges Bank
Norway
$11.6M +$1.5M +53,077 +13%
CS
29
Candriam SCA
Luxembourg
$11.3M -$1.1M -39,000 -8%
Bessemer Group
30
Bessemer Group
New Jersey
$11M – – –
Charles Schwab
31
Charles Schwab
California
$10.9M +$148K +5,238 +1%
Citadel Advisors
32
Citadel Advisors
Florida
$9.16M +$7.62M +270,483 +290%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$6.76M +$9.64K +342 +0.1%
BBA
34
Baker Bros. Advisors
New York
$5.59M – – –
N
35
Nuveen
North Carolina
$5.44M -$3.56M -126,158 -37%
DCM
36
DAFNA Capital Management
California
$5.34M +$70.5K +2,500 +1%
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$4.54M +$4.31M +152,940 +558%
Rafferty Asset Management
38
Rafferty Asset Management
New York
$3.96M +$1.64M +58,257 +59%
MB
39
MPM BioImpact
Massachusetts
$3.68M -$112K -3,959 -3%
Citigroup
40
Citigroup
New York
$3.42M +$1.76M +62,564 +85%
Two Sigma Investments
41
Two Sigma Investments
New York
$3.21M +$395K +14,011 +12%
UBS Group
42
UBS Group
Switzerland
$2.88M -$82.6K -2,930 -2%
AllianceBernstein
43
AllianceBernstein
Tennessee
$2.66M +$549K +19,482 +23%
Swiss National Bank
44
Swiss National Bank
Switzerland
$2.65M – – –
JMPWA
45
JP Morgan Private Wealth Advisors
California
$2.49M – – –
Deutsche Bank
46
Deutsche Bank
Germany
$2.27M +$25.6K +907 +1%
Two Sigma Advisers
47
Two Sigma Advisers
New York
$2.15M +$552K +19,600 +30%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$2.02M -$21.3K -754 -0.9%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$1.93M – – –
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$1.92M +$110K +3,910 +5%
1
2
3 4 5

RVMD Hedge Fund Activity: Q4 2021 in Review

117 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines (RVMD) for Q4 2021, worth a combined $1.85B — down 7.2% from $1.99B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new RVMD positions and 15 closed out — a net gain of 4 holders — while 40 added to existing stakes and 29 trimmed.

The largest buyer was Woodline Partners, adding an estimated $58.1M. The largest seller was Fidelity Investments, cutting an estimated $47.8M.

  • 117 institutional investors held Revolution Medicines (RVMD) as of Q4 2021, up from 114 in Q3 2021.
  • Funds reported $1.85B of Revolution Medicines stock for Q4 2021, down 7.2% quarter-over-quarter.
  • 19 funds opened new Revolution Medicines positions in Q4 2021 and 15 closed out, a net change of +4 holders.
  • The largest Revolution Medicines buyer in Q4 2021 was Woodline Partners, an estimated $58.1M added.
  • The largest Revolution Medicines seller in Q4 2021 was Fidelity Investments, an estimated $47.8M sold.

Based on aggregated 13F filings for Q4 2021.